|Evaluation of the Cockroft–Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients|
GM Marx, GM Blake, E Galani, CB Steer, SE Harper, KL Adamson, ...
Annals of oncology 15 (2), 291-295, 2004
|Enzalutamide with standard first-line therapy in metastatic prostate cancer|
ID Davis, AJ Martin, MR Stockler, S Begbie, KN Chi, S Chowdhury, ...
New England Journal of Medicine 381 (2), 121-131, 2019
|Denosumab and bone metastasis–free survival in men with nonmetastatic castration-resistant prostate cancer: Exploratory analyses by baseline prostate-specific antigen doubling time|
MR Smith, F Saad, S Oudard, N Shore, K Fizazi, P Sieber, B Tombal, ...
Journal of Clinical Oncology 31 (30), 3800, 2013
|Phase II study of thalidomide in the treatment of recurrent glioblastoma multiforme|
GM Marx, N Pavlakis, S McCowatt, FM Boyle, JA Levi, DR Bell, R Cook, ...
Journal of neuro-oncology 54 (1), 31-38, 2001
|First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE …|
HS Wasan, P Gibbs, NK Sharma, J Taieb, V Heinemann, J Ricke, ...
The Lancet Oncology 18 (9), 1159-1171, 2017
|Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling|
L Zhao, BY Lee, DA Brown, MP Molloy, GM Marx, N Pavlakis, MJ Boyer, ...
Cancer research 69 (19), 7696-7703, 2009
|Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer|
HM Lin, L Castillo, KL Mahon, K Chiam, BY Lee, Q Nguyen, MJ Boyer, ...
British journal of cancer 110 (10), 2462-2471, 2014
|Primary treatment of the prostate improves local palliation in men who ultimately develop castrate‐resistant prostate cancer|
ACM Won, H Gurney, G Marx, P De Souza, MI Patel
BJU international 112 (4), E250-E255, 2013
|Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab …|
R Von Moos, JJ Body, B Egerdie, A Stopeck, JE Brown, D Damyanov, ...
Supportive Care in Cancer 21 (12), 3497-3507, 2013
|Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: time to take stock!|
GM Marx, CB Steer, P Harper, N Pavlakis, O Rixe, D Khayat
Journal of clinical oncology 20 (6), 1446-1448, 2002
|Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised …|
C Eng, TW Kim, J Bendell, G Argilés, NC Tebbutt, M Di Bartolomeo, ...
The Lancet Oncology 20 (6), 849-861, 2019
|Pseudomyxoma peritonei: the ‘controversial’disease|
E Galani, GM Marx, CB Steer, G Culora, PG Harper
International Journal of Gynecologic Cancer 13 (4), 2003
|Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate …|
KL Mahon, W Qu, J Devaney, C Paul, L Castillo, RJ Wykes, MD Chatfield, ...
British journal of cancer 111 (9), 1802-1809, 2014
|Influenza vaccination and chemotherapy: a shot in the dark?|
A Ring, G Marx, C Steer, P Harper
Supportive care in cancer 10 (6), 462-465, 2002
|Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer|
M Khasraw, N Pavlakis, S McCowatt, C Underhill, S Begbie, P de Souza, ...
Annals of oncology 21 (6), 1302-1307, 2010
|Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer|
KL Mahon, HM Lin, L Castillo, BY Lee, M Lee-Ng, MD Chatfield, K Chiam, ...
British journal of cancer 112 (8), 1340-1348, 2015
|Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases|
R von Moos, JJ Body, B Egerdie, A Stopeck, J Brown, L Fallowfield, ...
Supportive Care in Cancer 24 (3), 1327-1337, 2016
|Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab|
NC Tebbutt, F Murphy, D Zannino, K Wilson, MM Cummins, E Abdi, ...
Annals of oncology 22 (8), 1834-1838, 2011
|The predictive role of serum VEGF in an advanced malignant mesothelioma patient cohort treated with thalidomide alone or combined with cisplatin/gemcitabine|
SCH Kao, R Harvie, F Paturi, R Taylor, R Davey, R Abraham, S Clarke, ...
Lung Cancer 75 (2), 248-254, 2012
|Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy|
E Hovey, P de Souza, G Marx, P Parente, T Rapke, A Hill, A Bonaventura, ...
Supportive Care in Cancer 22 (5), 1233-1242, 2014